Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Hologic, Inc.

NASDAQ

Market Cap.

17.22B

Avg. Volume

1.55M

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Hologic, Inc.!

Still processing it, give me a bit more time...

Hologic, Inc. News

Hologic, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Website screenshot
HealthcareMedical - Instruments & Supplies
hologic.com

About Hologic, Inc.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

Hologic, Inc. Earnings & Revenue

Hologic, Inc. Financials

Table Compare

Compare HOLX metrics with:

   

Earnings & Growth

HOLX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

HOLX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

HOLX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

HOLX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Hologic, Inc. Income

Hologic, Inc. Balance Sheet

Hologic, Inc. Cash Flow

Hologic, Inc. Financials Over Time

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Hologic, Inc. Executives

NameRole
Mr. Stephen P. MacMillanChairman, Chief Executive Officer & President
Ms. Karleen M. ObertonChief Financial Officer
Mr. John M. GriffinGeneral Counsel
Mr. Jan VerstrekenGroup President of International
Mr. Essex D. MitchellChief Operating Officer
NameRoleGenderDate of BirthPay
Mr. Stephen P. MacMillanChairman, Chief Executive Officer & PresidentMale19644.12M
Ms. Karleen M. ObertonChief Financial OfficerFemale19701.6M
Mr. John M. GriffinGeneral CounselMale19611.47M
Mr. Jan VerstrekenGroup President of InternationalMale19681.44M
Mr. Essex D. MitchellChief Operating OfficerMale1980925.29K

Hologic, Inc. Insider Trades

Date23 May
NameMACMILLAN STEPHEN P
RoleChairman, President and CEO
TransactionDisposed
TypeG-Gift
Shares57875
Date19 Apr
NameMACMILLAN STEPHEN P
RoleChairman, President and CEO
TransactionDisposed
TypeG-Gift
Shares12000
Date22 Apr
NameMACMILLAN STEPHEN P
RoleChairman, President and CEO
TransactionDisposed
TypeG-Gift
Shares12000
Date14 Mar
NameGARRETT SCOTT T
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares9039
Date14 Mar
NameGARRETT SCOTT T
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares7402
DateNameRoleTransactionTypeShares
23 MayMACMILLAN STEPHEN PChairman, President and CEODisposedG-Gift57875
19 AprMACMILLAN STEPHEN PChairman, President and CEODisposedG-Gift12000
22 AprMACMILLAN STEPHEN PChairman, President and CEODisposedG-Gift12000
14 MarGARRETT SCOTT TDirectorAcquiredM-Exempt9039
14 MarGARRETT SCOTT TDirectorAcquiredM-Exempt7402

Discover More

Streamlined Academy

Hologic, Inc.

NASDAQ

Market Cap.

17.22B

Avg. Volume

1.55M

Price

1W %

1M %

3M %

6M %

1Y %

YTD %

--

--

--

--

--

--

--

Hologic, Inc. News

Hologic, Inc. Score

Overall Score

Growth

Value

Quality

Moment.

Momentum

Stability

Hologic, Inc. Earnings & Revenue

Hologic, Inc. Income

Hologic, Inc. Balance Sheet

Hologic, Inc. Cash Flow

Hologic, Inc. Financials Over Time

Hologic, Inc. Executives

NameRole
Mr. Stephen P. MacMillanChairman, Chief Executive Officer & President
Ms. Karleen M. ObertonChief Financial Officer
Mr. John M. GriffinGeneral Counsel
Mr. Jan VerstrekenGroup President of International
Mr. Essex D. MitchellChief Operating Officer
NameRoleGenderDate of BirthPay
Mr. Stephen P. MacMillanChairman, Chief Executive Officer & PresidentMale19644.12M
Ms. Karleen M. ObertonChief Financial OfficerFemale19701.6M
Mr. John M. GriffinGeneral CounselMale19611.47M
Mr. Jan VerstrekenGroup President of InternationalMale19681.44M
Mr. Essex D. MitchellChief Operating OfficerMale1980925.29K

Hologic, Inc. Insider Trades

Date23 May
NameMACMILLAN STEPHEN P
RoleChairman, President and CEO
TransactionDisposed
TypeG-Gift
Shares57875
Date19 Apr
NameMACMILLAN STEPHEN P
RoleChairman, President and CEO
TransactionDisposed
TypeG-Gift
Shares12000
Date22 Apr
NameMACMILLAN STEPHEN P
RoleChairman, President and CEO
TransactionDisposed
TypeG-Gift
Shares12000
Date14 Mar
NameGARRETT SCOTT T
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares9039
Date14 Mar
NameGARRETT SCOTT T
RoleDirector
TransactionAcquired
TypeM-Exempt
Shares7402
DateNameRoleTransactionTypeShares
23 MayMACMILLAN STEPHEN PChairman, President and CEODisposedG-Gift57875
19 AprMACMILLAN STEPHEN PChairman, President and CEODisposedG-Gift12000
22 AprMACMILLAN STEPHEN PChairman, President and CEODisposedG-Gift12000
14 MarGARRETT SCOTT TDirectorAcquiredM-Exempt9039
14 MarGARRETT SCOTT TDirectorAcquiredM-Exempt7402

Streamlined Academy

Website screenshot
HealthcareMedical - Instruments & Supplies
hologic.com

About Hologic, Inc.

Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. It operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. The company provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load tests for HIV, Hepatitis C, and Hepatitis B; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays for the detection of SARS-CoV-2; ThinPrep System for use in cytology applications; Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth; and various diagnostic tests for the detection of Group B Streptococcus. It also offers breast imaging and analytics, such as 2D and 3D digital mammography systems and reading workstations, minimally invasive breast biopsy guidance systems and devices, breast biopsy site markers and localization, specimen radiology, and ultrasound and connectivity solutions; and breast conserving surgery products. In addition, the company provides NovaSure Endometrial Ablation System for the treatment of abnormal uterine bleeding; MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids, polyps, and other pathology within the uterus; and Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures. Further, it offers Horizon DXA, a dual energy X-ray system; and the Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. The company sells its products through direct sales and service forces, and independent distributors and sales representatives. Hologic, Inc. was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.

AI Analyst

AI

Streamlined AI Analyst

Hi I’m your personal financial assistant, click on one of the options below and I’ll help you analyze Hologic, Inc.!

Still processing it, give me a bit more time...

Hologic, Inc. Financials

Table Compare

Compare HOLX metrics with:

   

Earnings & Growth

HOLX

None

EPS (TTM) YoY Growth

--

--

Revenue (TTM) YoY Growth

--

--

 

Valuation (TTM)

HOLX

None

Price/Earnings Ratio

--

--

Price/Sales Ratio

--

--

 

Profitability & Efficiency (TTM)

HOLX

None

Net Profit Margin

--

--

Return on Equity

--

--

 

Financial Health (TTM)

HOLX

None

Debt Ratio

--

--

Quick Ratio

--

--

 

Hologic, Inc. Valuation

Project future cash flows and get the intrinsic value per share.

Start valuation modeling

Analysts Rating

Strong Buy

Buy

Hold

Sell

Strong Sell

Metrics Scores

MetricsScore
Discounted Cash FlowsStrong Buy
Return on EquityBuy
Return on AssetsStrong Buy
Debt/Equity RatioBuy
Price/Earnings RatioStrong Buy
Price/Book RatioBuy

Price Targets


Disclaimer: This 3rd party analysis information is for reference only and does not constitute investment advice.

Historical Market Cap

Shares Outstanding

Discover More